Company news
Panbela Therapeutics, Inc. news in 2017
Panbela Therapeutics, Inc.'s news releases, calls and decks from 2017, newest first.
Sun BioPharma Announces Execution of Reverse Stock Split
November 7, 2017
Sun BioPharma Achieves Significant Milestone with Successful Completion of Patient Enrollment in Phase 1a Dose Escalation Safety Study of SBP-101 for Patients with Pancreatic Cancer
October 4, 2017
Sun BioPharma Files Form 10-Q for Second Quarter 2017 and Provides Clinical Update
August 10, 2017
Sun BioPharma, Inc. to Present at the 2017 Marcum MicroCap Conference in New York on June 15, 2017
June 7, 2017
Sun BioPharma, Inc. Announces Completion of the Fifth Patient Cohort in the Dose Escalation Phase 1a Study of SBP-101 for Pancreatic Cancer
June 7, 2017
Sun BioPharma Reports First Quarter 2017 Results
May 11, 2017
Sun BioPharma Provides Phase 1 Trial Update; Patients Experience Early Signs of Efficacy
March 30, 2017
The NIH Awards Sun BioPharma, Inc. Grant to Study SBP-101 for the Treatment of Pancreatitis
February 1, 2017
Decks in 2017
- Sun BioPharma — Investor Presentation (December 2017)
Investor deck · 28 slides · Dec 4, 2017